Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine ; volume:17 ; number:1 ; day:24 ; month:5 ; year:2019 ; pages:1-18 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (24.5.2019), 1-18, 12.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1924-1
- URN
-
urn:nbn:de:101:1-2019091903581492914522
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schwerdtfeger, Melanie
- Andersson, Anne-Marie Carola
- Neukirch, Lasse
- Holst, Peter Johannes
- SpringerLink (Online service)
Other Objects (12)
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
Designed virus-like particles as novel modular vaccine delivery system for synthetic peptide antigens
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
Evaluation of a replication-competent VSV-SIV vaccine candidate
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Virus-like structures for combination antigen protein mRNA vaccination
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
Designed virus-like particles as novel modular vaccine delivery system for synthetic peptide antigens
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
Evaluation of a replication-competent VSV-SIV vaccine candidate
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Virus-like structures for combination antigen protein mRNA vaccination
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
Designed virus-like particles as novel modular vaccine delivery system for synthetic peptide antigens
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
Evaluation of a replication-competent VSV-SIV vaccine candidate
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Virus-like structures for combination antigen protein mRNA vaccination
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches